Obama’s Precision Medicine Initiative covers new ground with veterans

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

President Obama is holding a summit to discuss the next steps in his year-old Precision Medicine Initiative, laying the groundwork for long-term research that administration officials hope will continue after he leaves office.

The new measures include a pilot program investigating how to recruit participants, draft security provisions for the medical data that will be collected, and an expansion of the Department of Veterans Affairs’ Million Veteran Program to collect medical data from active-duty military personnel, administration officials said in a call with reporters.

Obama’s involvement shows that he “cares a lot about this topic and this initiative,” said John Holdren, director of the White House Office of Science and Technology Policy. The broad participation in the summit, which will feature 170 people from government agencies, private research institutions, and patient groups, shows that “this is an all-hands-on-deck operation,” he said.

Obama announced the Precision Medicine Initiative last year to accelerate research into treatments tailored to individual patients. He’s asking Congress for $309 million for the initiative next year, an increase of more than $100 million over this year’s spending.

Read full, original post: Obama pushes precision medicine research, with help from Google

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
ChatGPT-Image-Mar-27-2026-11_27_05-AM
The myths of “process”: What science says about the “dangers’ of synthetic products and ultra-processed foods
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Mar-3-2026-01_17_14-PM
MAHA wellness influencers deride proven anxiety medications, tout lifestyle fixes
ChatGPT-Image-Apr-30-2026-12_21_05-PM-2
The tech billionaires behind the immortality movement
ChatGPT-Image-Apr-30-2026-05_00_48-PM
Wellness grifter physician turned wellness influencer out as surgeon general nominee
ChatGPT Image Apr 30, 2026, 01_11_41 PM
Trump’s America First health aid cuts: Retrenchment has already hit global malaria, HIV, TB, and polio programs
ChatGPT-Image-Feb-16-2026-01_57_31-PM
Viewpoint: ‘Science-as-Satan’ unites the MAHA—MAGA movements. Is a breakup in the works?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.